Aggressive natural killer cell leukemia therapy in the L-asparaginase era: why are we failing?
{{output}}
Purpose: Aggressive natural killer cell leukemia (ANKL) is a rare malignancy with poor prognosis and unclear treatment strategies. Given the poor prognosis and lack of a standardized treatment for ANKL, this study aimed to evalua... ...
